September 17, 2026 · Blood · DOI: 10.1182/blood.2026034181

IDH3 regulates citrate homeostasis to control metabolic fitness and venetoclax resistance of AML stem cells

Listen to this summary

The authors investigate the role of isocitrate dehydrogenase 3 (IDH3) in regulating metabolic fitness and resistance to venetoclax in acute myeloid leukemia (AML) stem cells. They find that IDH3 is crucial for maintaining the tricarboxylic acid (TCA) cycle activity in leukemic stem cells, and its downregulation leads to a metabolic crisis that enhances susceptibility to BCL2 inhibition. The study suggests that targeting the IDH3A-citrate axis could be a potential strategy to overcome treatment resistance in AML patients.

Aykut Demir, Maximilian Mönnig, Nesrine Aroua, Eleni Besiridou, Valentin Schmidt, Kristina Müller, Simon Renders, Fabian Schulte, Alireza Pouya, Alexander Waclawiczek, Aino-Maija Leppä, Karolin Stumpf, Markus Sohn, Dominic Depke, Patrick Wuchter, Darja Karpova, Elisa Donato, Halvard Bonig, Carolin Andresen, Michael Büttner, Gernot Poschet, Daniel Hübschmann, Nicola Zamboni, Tim Sauer, Andreas Trumpp, Carsten Müller-Tidow, Simon Raffel

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play